Related Experiment Video
Updated: Jun 18, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome
Thornik Reimer1, Michael H Shaw, Luigi Franchi
1Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Abstract:
Cerebral malaria is the most severe complication of Plasmodium falciparum infection in humans and the pathogenesis is still unclear. Using the P. berghei ANKA infection model of mice, we investigated a potential involvement of Nlrp3 and the inflammasome in the pathogenesis of cerebral malaria. Nlrp3 mRNA expression was upregulated in brain endothelial cells after exposure to P. berghei ANKA. Although beta-hematin, a synthetic compound of the parasites heme polymer hemozoin, induced the release of IL-1beta in macrophages through Nlrp3, we did not obtain evidence for a role of IL-1beta in vivo. Nlrp3 knock-out mice displayed a delayed onset of cerebral malaria; however, mice deficient in caspase-1, the adaptor protein ASC or the IL-1 receptor succumbed as WT mice. These results indicate that the role of Nlrp3 in experimental cerebral malaria is independent of the inflammasome and the IL-1 receptor pathway.
Insights
Nlrp3 inflammasome activation is not essential for cerebral malaria pathogenesis. Nlrp3 plays a role independent of IL-1beta signaling in this severe Plasmodium falciparum complication.
Area of Science:
- Immunology
- Pathology
- Infectious Diseases
Background:
- Cerebral malaria, a severe Plasmodium falciparum complication, has unclear pathogenesis.
- The role of Nlrp3 inflammasome in cerebral malaria requires further investigation.
Purpose of the Study:
- To investigate the involvement of Nlrp3 and the inflammasome in experimental cerebral malaria pathogenesis.
- To elucidate the specific pathways mediated by Nlrp3 in this condition.
Main Methods:
- Utilized the P. berghei ANKA mouse model for experimental cerebral malaria.
- Analyzed Nlrp3 mRNA expression in brain endothelial cells.
- Investigated the effects of beta-hematin on IL-1beta release in macrophages.
- Compared disease progression in Nlrp3 knockout mice versus wild-type and inflammasome-component deficient mice.
Main Results:
- Nlrp3 mRNA expression was upregulated in brain endothelial cells during P. berghei ANKA infection.
- Beta-hematin induced Nlrp3-dependent IL-1beta release in macrophages, but IL-1beta did not appear to play a role in vivo.
- Nlrp3 knockout mice showed a delayed onset of cerebral malaria.
- Mice deficient in caspase-1, ASC, or the IL-1 receptor exhibited outcomes similar to wild-type mice.
Conclusions:
- Nlrp3 contributes to experimental cerebral malaria pathogenesis independently of the inflammasome and IL-1 receptor signaling.
- The findings suggest a novel, inflammasome-independent role for Nlrp3 in cerebral malaria.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Malaria
Bacterial Meningitis II: Pathophysiology
Arboviral Encephalitis
Bacterial Meningitis

